138 related articles for article (PubMed ID: 85253)
21. Chemotherapy of disseminated seminoma.
Einhorn LH; Williams SD
Cancer Clin Trials; 1980; 3(4):307-13. PubMed ID: 6159120
[TBL] [Abstract][Full Text] [Related]
22. Treatment of disseminated testicular tumors with combination of cis-platinum, vinblastine, bleomycin and actinomycin D.
Roth A; Kolarić K
Oncology; 1985; 42(4):248-52. PubMed ID: 2409495
[TBL] [Abstract][Full Text] [Related]
23. Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients.
Comis RL; Kuppinger MS; Ginsberg SJ; Crooke ST; Gilbert R; Auchincloss JH; Prestayko AW
Cancer Res; 1979 Dec; 39(12):5076-80. PubMed ID: 91430
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum chemotherapy regimen with and without maintenance in patients with resected stage IIB testis cancer.
Vugrin D; Whitmore WF; Herr H; Sogani P; Golbey RB
J Urol; 1982 Oct; 128(4):715-7. PubMed ID: 6183456
[TBL] [Abstract][Full Text] [Related]
25. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum combination chemotherapy in metastatic testis cancer--a 1-year program.
Vugrin D; Whitmore WF; Golbey RB
J Urol; 1982 Dec; 128(6):1205-8. PubMed ID: 6185697
[TBL] [Abstract][Full Text] [Related]
26. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
[TBL] [Abstract][Full Text] [Related]
27. Enhanced effects of bleomycin on pulmonary function disturbances in patients with decreased renal function due to cisplatin.
Sleijfer S; van der Mark TW; Schraffordt Koops H; Mulder NH
Eur J Cancer; 1996 Mar; 32A(3):550-2. PubMed ID: 8814706
[TBL] [Abstract][Full Text] [Related]
28. Five-year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycin.
Stoter G; Vendrik CP; Struyvenberg A; Sleyfer DT; Vriesendorp R; Schraffordt Koops H; van Oosterom AT; ten Bokkel Huinink WW; Pinedo HM
Cancer; 1984 Oct; 54(8):1521-4. PubMed ID: 6206937
[TBL] [Abstract][Full Text] [Related]
29. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. 1997.
Einhorn LH; Donohue J
J Urol; 2002 Feb; 167(2 Pt 2):928-32; discussion 933. PubMed ID: 11905920
[No Abstract] [Full Text] [Related]
30. Vinblastine, bleomycin, and cis-dichlorodiammineplatinum(II) in disseminated testicular cancer: preliminary report of a Southwest Oncology Group Study.
Samson MK; Stephens RL; Rivkin S; Opipari M; Maloney T; Groppe CW; Fisher R
Cancer Treat Rep; 1979; 63(9-10):1663-7. PubMed ID: 91435
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy of germ cell tumors of the testis. I. Induction of remissions with vinblastine, actinomycin D, and bleomycin.
Wittes RE; Yagoda A; Silvay O; Magill GB; Whitmore W; Krakoff IH; Golbey RB
Cancer; 1976 Feb; 37(2):637-45. PubMed ID: 56214
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of bleomycin pulmonary toxicity on the outcomes of patients with germ cell tumors.
Maruyama Y; Sadahira T; Mitsui Y; Araki M; Wada K; Tanimoto R; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y
Med Oncol; 2018 Apr; 35(6):80. PubMed ID: 29700638
[TBL] [Abstract][Full Text] [Related]
33. Influence of platinum-induced renal toxicity on bleomycin-induced pulmonary toxicity in patients with disseminated testicular carcinoma.
van Barneveld PW; Sleijfer DT; van der Mark TW; Mulder NH; Donker AJ; Meijer S; Schraffordt Koops H; Sluiter HJ; Peset R
Oncology; 1984; 41(1):4-7. PubMed ID: 6199706
[TBL] [Abstract][Full Text] [Related]
34. Advanced male non-seminomatous germ-cell tumours. Combination chemotherapy with cis-platinum, vinblastine and bleomycin.
Woods RL; Fox RM; Tattersall MH
Med J Aust; 1979 Dec; 2(12):630-2. PubMed ID: 94148
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin-converting enzyme: an indicator of bleomycin-induced pulmonary toxicity in humans?
Sørensen PG; Rømer FK; Cortes D
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1405-8. PubMed ID: 6209143
[TBL] [Abstract][Full Text] [Related]
36. The effect of corticosteroid administration on bleomycin lung toxicity.
Jensen JL; Goel R; Venner PM
Cancer; 1990 Mar; 65(6):1291-7. PubMed ID: 1689606
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy of disseminated testicular cancer.
Williams SD; Einhorn LH
Ariz Med; 1978 Sep; 35(9):595-7. PubMed ID: 81667
[No Abstract] [Full Text] [Related]
38. [Sequential combination chemotherapy with vinblastine/bleomycin and adriamycin/cis-dichlorodiammineplatinum (II) in non-seminomatous testicular cancer. I. Results of a prospective randomized phase III-study with 71 patients with disseminated disease (stage IV) (author's transl)].
Scheulen ME; Higi M; Schilcher RB; Meier CR; Seeber S; Schmidt CG
Klin Wochenschr; 1980 Aug; 58(16):811-21. PubMed ID: 6161273
[TBL] [Abstract][Full Text] [Related]
39. Bleomycin lung: the effect of different chemotherapeutic regimens.
Chisholm RA; Dixon AK; Williams MV; Oliver RT
Cancer Chemother Pharmacol; 1992; 30(2):158-60. PubMed ID: 1376217
[TBL] [Abstract][Full Text] [Related]
40. Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.
Logothetis CJ; Samuels ML; Selig D; Swanson D; Johnson DE; von Eschenbach AC
J Clin Oncol; 1985 Mar; 3(3):326-35. PubMed ID: 2579213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
